Stocks
Neurocrine Biosciences (NBIX) Net debt US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net debt, bln rub | -175.0 | -388.7 | -270.9 | -726.4 | -603.2 | -976.6 | |||
| Changes by years, y/y, % | -33% | +122% | -30% | +168% | -17% | +18.1% | |||
Neurocrine Biosciences. Net debt, bln rub
Neurocrine Biosciences. Net debt, changes, %
Neurocrine Biosciences (NBIX) Net debt US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Net debt, bln rub | -839.3 | -603.2 | -663.7 | -747.3 | -976.6 | -976.6 | ||
| Changes by years, y/y, % | +57% | -17% | +5% | +4% | +16% | |||
| Changes by quarters, q/q, % | +17% | -28% | +10% | +13% | +31% | |||
